CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class ...
FORT LAUDERDALE, Fla., Oct. 24, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback